Anthrax -- United States
The Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical and Biological Defense, has announced the development of a Biological Select Agents and Toxins (BSAT) surrogate solution that will mitigate the risks associated with shipment and use of Bacillus anthracis.
In addition to risk mitigation for Department of Defense (DoD) stakeholders and the community at large, this product demonstrates DBPAO's commitment to providing quality
Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2rUpKR8
No comments:
Post a Comment